Loading data
ESABNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.84 bn USD | 2.74 bn USD | 2.77 bn USD | 2.59 bn USD | 2.43 bn USD |
| Cost of revenue | 1.79 bn USD | 1.7 bn USD | 1.76 bn USD | 1.71 bn USD | 1.59 bn USD |
| Gross profit | 1.05 bn USD | 1.04 bn USD | 1.02 bn USD | 885.53 m USD | 837.98 m USD |
| Research and development expense | 44 m USD | 39.2 m USD | 38.8 m USD | 36 m USD | 39.7 m USD |
| Selling, general and administrative expense | 608.42 m USD | 579.78 m USD | 587.48 m USD | 533.37 m USD | 512.82 m USD |
| Operating profit | 412.17 m USD | 447.45 m USD | 404.17 m USD | 329.07 m USD | 306.21 m USD |
| Profit before tax | 328.26 m USD | 370.41 m USD | 319.09 m USD | 300.25 m USD | 319.09 m USD |
| Income tax expense | 69.16 m USD | 77.35 m USD | 95.73 m USD | 69.17 m USD | 80.41 m USD |
| Net income (reported basis) | 226.77 m USD | 264.84 m USD | 205.29 m USD | 223.75 m USD | 235.11 m USD |
| Net income attributable to common shareholders | 251.42 m USD | 285.78 m USD | 216.07 m USD | 225.22 m USD | 235.11 m USD |
| Basic earnings per share | 3.71 USD/share | 4.36 USD/share | 3.39 USD/share | 3.7 USD/share | 3.92 USD/share |
| Diluted earnings per share | 3.67 USD/share | 4.31 USD/share | 3.36 USD/share | 3.69 USD/share | 3.92 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.